Sunday, March 23, 2025 3:12:51 PM
You are actually saying that a takeover for $10,- and then converting that money into BP shares (of the acquiring party) will be very nice.
I will give you an example: at $10,- per share we have a factor of 40 at the moment.
If we go to BP with that money, it will still be quite a job to double its stock price. But okay then we would have a factor of 80 compared to now.
A factor of 80 compared to now is a price of $20,-.
Given the situation that LP has prepared (platform, licenses) and that they will very likely also develop with the current potential, I think of a price of AT LEAST $50,- pps. This is a Market Cap of approximately $85 billion. Much less than that of a BP like Merck or BMY but at that moment with a much higher potential because DCvax will take a lot from them and only grant them licenses as a kind of landlord.
And that is a factor 200 !
I will give you an example: at $10,- per share we have a factor of 40 at the moment.
If we go to BP with that money, it will still be quite a job to double its stock price. But okay then we would have a factor of 80 compared to now.
A factor of 80 compared to now is a price of $20,-.
Given the situation that LP has prepared (platform, licenses) and that they will very likely also develop with the current potential, I think of a price of AT LEAST $50,- pps. This is a Market Cap of approximately $85 billion. Much less than that of a BP like Merck or BMY but at that moment with a much higher potential because DCvax will take a lot from them and only grant them licenses as a kind of landlord.
And that is a factor 200 !
Bullish
Recent NWBO News
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
